Trials / Completed
CompletedNCT05964088
Mortality and Morbidity Associated With New Onset Acute Kidney Injury in Critically Ill COVID-19 Infection Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 267 (actual)
- Sponsor
- Arrowhead Regional Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This study explored the incidence of morbidity and mortality associated with AKI in critically ill adult patients infected with COVID-19. There are two groups for comparison. Group1. patients were directly admitted to the intensive care unit (ICU) from the emergency department (ED) Group 2. patients were initially managed on the medical floor and later transferred to the ICU for worsening respiratory status. The investigating team evaluated the correlation of inflammatory markers and common risk factors such as obesity, diabetes, hypertension and ethnicity to the development of AKI in the target population. The primary outcome is mortality participants will received their regular healthcare in a medical setting
Conditions
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2022-02-12
- Completion
- 2022-02-12
- First posted
- 2023-07-27
- Last updated
- 2023-07-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05964088. Inclusion in this directory is not an endorsement.